174 related articles for article (PubMed ID: 2574910)
1. Omeprazole in the management of refractory duodenal ulcer.
Bardhan KD
Scand J Gastroenterol Suppl; 1989; 166():63-73. PubMed ID: 2574910
[TBL] [Abstract][Full Text] [Related]
2. Is there any acid peptic disease that is refractory to proton pump inhibitors?
Bardhan KD
Aliment Pharmacol Ther; 1993; 7 Suppl 1():13-24, discussion 29-31. PubMed ID: 8490075
[TBL] [Abstract][Full Text] [Related]
3. Treatment of refractory peptic ulcer with omeprazole or continued H2 receptor antagonists: a controlled clinical trial.
Bardhan KD; Naesdal J; Bianchi Porro G; Petrillo M; Lazzaroni M; Hinchliffe RF; Thompson M; Morris P; Daly MJ; Carroll NJ
Gut; 1991 Apr; 32(4):435-8. PubMed ID: 1673953
[TBL] [Abstract][Full Text] [Related]
4. Medical therapy of peptic ulcer disease.
McQuaid KR; Isenberg JI
Surg Clin North Am; 1992 Apr; 72(2):285-316. PubMed ID: 1347960
[TBL] [Abstract][Full Text] [Related]
5. The clinical utility and safety of omeprazole.
Walan A
Scand J Gastroenterol Suppl; 1989; 166():140-4; discussion 145. PubMed ID: 2574908
[TBL] [Abstract][Full Text] [Related]
6. Omeprazole in peptic ulcers resistant to histamine H2-receptor antagonists.
Tytgat GN; Lamers CB; Hameeteman W; Jansen JM; Wilson JA
Aliment Pharmacol Ther; 1987 Feb; 1(1):31-8. PubMed ID: 2908747
[TBL] [Abstract][Full Text] [Related]
7. Relationship between inhibition of acid secretion and healing of peptic ulcers.
Chiverton SG; Hunt RH
Scand J Gastroenterol Suppl; 1989; 166():43-7; discussion 74-5. PubMed ID: 2690331
[TBL] [Abstract][Full Text] [Related]
8. Irradiation-induced duodenal ulcer disease refractory to ranitidine: healing by omeprazole.
Koop H; Koop I; Klein M; Stumpf M; Massarrat S; Arnold R
J Clin Gastroenterol; 1989 Dec; 11(6):631-4. PubMed ID: 2573627
[TBL] [Abstract][Full Text] [Related]
9. Omeprazole in the treatment of duodenal ulcer.
Bianchi Porro G; Parente F
Scand J Gastroenterol Suppl; 1989; 166():48-53; discussion 74-5. PubMed ID: 2557670
[TBL] [Abstract][Full Text] [Related]
10. Omeprazole. An update of its pharmacology and therapeutic use in acid-related disorders.
Wilde MI; McTavish D
Drugs; 1994 Jul; 48(1):91-132. PubMed ID: 7525198
[TBL] [Abstract][Full Text] [Related]
11. Idiopathic gastric acid hypersecretion: treatment implications for refractory acid/peptic disorders.
Lewis JH
Aliment Pharmacol Ther; 1991; 5 Suppl 1():15-24. PubMed ID: 1888834
[TBL] [Abstract][Full Text] [Related]
12. Histamine H2 receptor antagonist-refractory oesophagitis: the efficacy of long-term omeprazole maintenance treatment.
Bardhan KD; Cherian P; Jones RB; Vaishnavi A; Manek S; Bishop A; Polak J; Brooks A; Morris P; Thompson M; D'Silva J; Parkin S; Patterson J; Gillon KR
Ital J Gastroenterol Hepatol; 1997 Dec; 29(6):515-9. PubMed ID: 9513825
[TBL] [Abstract][Full Text] [Related]
13. Progress with proton pump inhibitors in acid peptic disease: treatment of duodenal and gastric ulcer.
Florent C
Clin Ther; 1993; 15 Suppl B():14-21. PubMed ID: 7911399
[TBL] [Abstract][Full Text] [Related]
14. Omeprazole and H2-receptor antagonists in the acute treatment of duodenal ulcer, gastric ulcer and reflux oesophagitis: a meta-analysis.
Eriksson S; Långström G; Rikner L; Carlsson R; Naesdal J
Eur J Gastroenterol Hepatol; 1995 May; 7(5):467-75. PubMed ID: 7614110
[TBL] [Abstract][Full Text] [Related]
15. Omeprazole. An updated review of its pharmacology and therapeutic use in acid-related disorders.
McTavish D; Buckley MM; Heel RC
Drugs; 1991 Jul; 42(1):138-70. PubMed ID: 1718683
[TBL] [Abstract][Full Text] [Related]
16. Ranitidine bismuth citrate versus omeprazole triple therapy for the eradication of Helicobacter pylori and healing of duodenal ulcer.
Catalano F; Catanzaro R; Bentivegna C; Brogna A; Condorelli G; Cipolla R
Aliment Pharmacol Ther; 1998 Jan; 12(1):59-62. PubMed ID: 9692702
[TBL] [Abstract][Full Text] [Related]
17. [Omeprazole in the therapy of acid-induced diseases].
Simon B; Dammann HG; Müller P
Z Gastroenterol; 1987 Aug; 25 Suppl 3():146-51. PubMed ID: 2889299
[TBL] [Abstract][Full Text] [Related]
18. Omeprazole and ranitidine in long-term treatment of duodenal ulcer: a double-blind comparison of length of time in remission.
Diaz de Rojas F; Berenguer J; Rodrigo L; Aran-Suau R; Da Silveira JC; Clerch L; Garcia Aparicio P; Caswell C
Dig Dis Sci; 1998 Sep; 43(9):1964-9. PubMed ID: 9753259
[TBL] [Abstract][Full Text] [Related]
19. Meta-analysis of randomized clinical trials comparing lansoprazole with ranitidine or famotidine in the treatment of acute duodenal ulcer.
Poynard T; Lemaire M; Agostini H
Eur J Gastroenterol Hepatol; 1995 Jul; 7(7):661-5. PubMed ID: 8590162
[TBL] [Abstract][Full Text] [Related]
20. Non-steroidal anti-inflammatory drug gastropathy: clinical results with H2 antagonists and proton pump inhibitors.
Lazzaroni M; Bianchi Porro G
Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S73-8. PubMed ID: 10379473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
